Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Based on the Phase 2 results and the speed of Eli Lillys development timeline, analysts expect an FDA submission sometime in 2025 or 2026, with potential approval following 12 to 18 months after submission if the data holds
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
Whether the dose-reduction strategy translates as cleanly for someone using the drug for both type 2 diabetes and weight management is a different question
Do not exceed 1 gram of paracetamol per dose or 4 grams per day
A T-score of -1.0 or higher is considered normal
Under the brand name Wegovy, it is indicated for weight management in non-diabetic populations with weight-related comorbidities [6, 7]
US$ 24.34
US$ 25.46
US$ 24.62
US$ 22.67
US$ 21.15
